Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Launched by DUKE UNIVERSITY · Oct 1, 2024
Trial Information
Current as of June 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how different factors affect the health and survival of adults with glioblastoma (GBM), a serious type of brain cancer. Researchers want to find out how things like genetics (the information in our DNA) and the immune system (the body's defense against illness) impact how long patients live and their quality of life. They are also interested in how a person's work history and medical background might relate to their risk of developing GBM.
If you or someone you know has been diagnosed with GBM and is at least 18 years old, you may be eligible to participate. Participants will complete an online survey about their health and lifestyle, and they will have the option to provide a blood sample for testing, which can be done at home using a kit sent by the study team. This study is currently recruiting participants, and it’s important to note that you should be able to read English or Spanish and access the online survey to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old
- • Pathologically-confirmed diagnosis of glioblastoma multiforme (GBM) or grade 4 brain tumor
- • Participant is accessible for follow-up (has a working email address)
- • Participant is willing and able to comply with the study requirements
- Exclusion Criteria:
- • Those who cannot read either English or Spanish
- • Those who cannot view an online survey
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Kyle M Walsh, PhD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported